Trials / Unknown
UnknownNCT01918969
Reference Values of Circulating Endothelial Progenitor Cells
Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Hopital Jean Minjoz · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been shown to be inversely correlated to aortic aneurysm size. However reference values have not yet been determined. This study is aimed to determine reference values of CD34+144+CD14- et CD34+VEGF-R2+CD14- in healthy men and women blood donors.
Detailed description
At the time of blood donation, 10mL of blood will be used to calculate the concentration of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- , and the ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all circulating endothelial progenitor cells in order to determine reference values.
Conditions
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-03-01
- First posted
- 2013-08-08
- Last updated
- 2013-08-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01918969. Inclusion in this directory is not an endorsement.